{
    "xml": "<topic id=\"PHP4787\" outputclass=\"drug\" rev=\"1.11\" type=\"drug\" namespace=\"/drugs/mifepristone\" basename=\"mifepristone\" title=\"MIFEPRISTONE\">\n<title>MIFEPRISTONE</title>\n<body>\r\n<p outputclass=\"interactionsLinks\"> List of individual interactants: <xref format=\"dita\" href=\"#bnf_int_614\" namespace=\"/interactions/list-of-drug-interactions/mifepristone\">Mifepristone</xref>\n</p>\n<data name=\"vtmid\">129483007</data>\n<data name=\"classifications\">\n<data name=\"classification\">\n<data name=\"drugClassification\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClassification\" href=\"#_407627730\" title=\"Progesterone receptor modulators\">Progesterone receptor modulators</xref>\n</data>\n</data>\n</data>\n<data name=\"primaryDomainOfEffect\">\n<data name=\"domainOfEffect\">  </data>\n</data>\r\n</body>\n<topic id=\"PHP61262\" outputclass=\"drugAction\" rev=\"1.7\" parent=\"/drugs/mifepristone\">\n<title>Drug action</title>\n<body>\n<section>\n<sectiondiv>\n<p>Mifepristone, an antiprogestogenic steroid, sensitises the myometrium to prostaglandin-induced contractions and ripens the cervix.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP61207\" outputclass=\"indicationsAndDose\" rev=\"1.35\" parent=\"/drugs/mifepristone\">\n<title>Indications and dose</title>\n<body>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Cervical ripening before mechanical cervical dilatation for termination of pregnancy of up to 84 days gestation (under close medical supervision)</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>200&#8239;mg for 1 dose, to be taken 36-48 hours before procedure.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Labour induction in fetal death in utero where prostaglandin or oxytocin inappropriate (under close medical supervision)</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>600&#8239;mg once daily for 2 days, if labour not started within 72 hours of first dose, another method should be used.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Medical termination of intra-uterine pregnancy of up to 49 days gestation (under close medical supervision)</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>600&#8239;mg for 1 dose, dose followed 36&#8211;48 hours later (unless abortion already complete) by gemeprost 1&#8239;mg by vagina <i>or</i> misoprostol 400&#8239;micrograms by mouth, alternatively 200&#8239;mg for 1 dose, dose followed 36&#8211;48 hours later (unless abortion already complete) by gemeprost 1&#8239;mg by vagina; observe for at least 3 hours (or until bleeding or pain at acceptable level); follow-up visit within 2 weeks to verify complete expulsion and to assess vaginal bleeding.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Medical termination of intra-uterine pregnancy of 50&#8211;63 days gestation (under close medical supervision)</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>600&#8239;mg for 1 dose, alternatively 200&#8239;mg for 1 dose, dose followed 36&#8211;48 hours later (unless abortion already complete) by gemeprost 1&#8239;mg by vagina; observe for at least 3 hours (or until bleeding or pain at acceptable level); follow-up visit within 2 weeks to verify complete expulsion and to assess vaginal bleeding.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Termination of pregnancy of 13&#8211;24 weeks gestation (in combination with a prostaglandin) (under close medical supervision)</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>600&#8239;mg for 1 dose, alternatively 200&#8239;mg for 1 dose, dose followed 36&#8211;48 hours later by gemeprost 1&#8239;mg by vagina every 3 hours up to max. 5 mg <i>or</i> misoprostol; if abortion does not occur, 24 hours after start of treatment repeat course of gemeprost 1&#8239;mg by vagina up to max. 5&#8239;mg; follow-up visit after appropriate interval to assess vaginal bleeding recommended.</p>\n</li>\n</ul>\n</section>\n</body>\n</topic>\n<topic id=\"PHP61298\" outputclass=\"contraindications\" rev=\"1.14\" parent=\"/drugs/mifepristone\">\n<title>Contra-indications</title>\n<body>\r\n<section outputclass=\"contraindications\">\r\n<p>\r\n<ph outputclass=\"contraindication\">\r\n<xref format=\"dita\" href=\"#PHP78608\" type=\"bookmark\" namespace=\"/treatment-summaries/acute-porphyrias\">Acute porphyrias</xref>\r\n</ph>; <ph outputclass=\"contraindication\">chronic adrenal failure</ph>; <ph outputclass=\"contraindication\">suspected ectopic pregnancy (use other specific means of termination)</ph>; <ph outputclass=\"contraindication\">uncontrolled severe asthma</ph>\r\n</p>\r\n </section>\r\n\r\n\r\n\r\n\r\n\r\n\r\n</body>\n</topic>\n<topic id=\"PHP61326\" outputclass=\"cautions\" rev=\"1.14\" parent=\"/drugs/mifepristone\">\n<title>Cautions</title>\n<body>\n<section outputclass=\"cautions\">\n<p>\n<ph outputclass=\"caution\">Adrenal suppression (may require corticosteroid)</ph>; <ph outputclass=\"caution\">anticoagulant therapy</ph>; <ph outputclass=\"caution\">asthma (avoid if severe and uncontrolled)</ph>; <ph outputclass=\"caution\">existing cardiovascular disease</ph>; <ph outputclass=\"caution\">haemorrhagic disorders</ph>; <ph outputclass=\"caution\">history of endocarditis</ph>; <ph outputclass=\"caution\">prosthetic heart valve</ph>; <ph outputclass=\"caution\">risk factors for cardiovascular disease</ph>\n</p>\n</section>\n</body>\n</topic>\n<topic id=\"PHP61188\" outputclass=\"interactions\" rev=\"1.9\" parent=\"/drugs/mifepristone\">\n<title>Interactions</title>\n<body>\n<section outputclass=\"general\">\n<sectiondiv>\n<p>Appendix 1 (mifepristone).</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP61093\" outputclass=\"sideEffects\" rev=\"1.8\" parent=\"/drugs/mifepristone\">\n<title>Side-effects</title>\n<body>\n<section outputclass=\"generalSideEffects\">\n<sectiondiv outputclass=\"frequencies\">\n<sectiondiv outputclass=\"commonOrVeryCommon\">\n<p outputclass=\"title\">Common or very common</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Gastro-intestinal cramps</ph>; <ph outputclass=\"sideEffect\">uterine contractions</ph>; <ph outputclass=\"sideEffect\">vaginal bleeding (sometimes severe) may occur between administration of mifepristone and surgery (and rarely abortion may occur before surgery)</ph>\n</p>\n</sectiondiv>\n<sectiondiv outputclass=\"uncommon\">\n<p outputclass=\"title\">Uncommon</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Hypersensitivity reactions</ph>; <ph outputclass=\"sideEffect\">rash</ph>; <ph outputclass=\"sideEffect\">urticaria</ph>\n</p>\n</sectiondiv>\n<sectiondiv outputclass=\"rare\">\n<p outputclass=\"title\">Rare</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Chills</ph>; <ph outputclass=\"sideEffect\">dizziness</ph>; <ph outputclass=\"sideEffect\">fever</ph>; <ph outputclass=\"sideEffect\">headache</ph>; <ph outputclass=\"sideEffect\">hot flushes</ph>; <ph outputclass=\"sideEffect\">hypotension</ph>; <ph outputclass=\"sideEffect\">malaise</ph>\n</p>\n</sectiondiv>\n<sectiondiv outputclass=\"notKnown\">\n<p outputclass=\"title\">Frequency not known</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Infections</ph>; <ph outputclass=\"sideEffect\">toxic shock syndrome</ph>\n</p>\n</sectiondiv>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP61235\" outputclass=\"hepaticImpairment\" parent=\"/drugs/mifepristone\">\n<title>Hepatic impairment</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Manufacturer advises avoid.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP61121\" outputclass=\"renalImpairment\" parent=\"/drugs/mifepristone\">\n<title>Renal impairment</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Manufacturer advises avoid.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP61047\" outputclass=\"monitoringRequirements\" parent=\"/drugs/mifepristone\">\n<title>Monitoring requirements</title>\n<body>\n<section outputclass=\"monitoringOfPatientParameters\">\n<sectiondiv>\n<p>Careful monitoring of blood pressure and pulse essential for 3 hours after administration of gemeprost pessary (risk of profound hypotension).</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP59428\" outputclass=\"prescribingAndDispensingInformation\" rev=\"1.8\" parent=\"/drugs/mifepristone\">\n<title>Prescribing and dispensing information</title>\n<body>\n<section>\n<sectiondiv>\n<p>Supplied to NHS hospitals and premises approved under Abortion Act 1967.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP61142\" outputclass=\"patientAndCarerAdvice\" rev=\"1.10\" parent=\"/drugs/mifepristone\">\n<title>Patient and carer advice</title>\n<body>\n<section outputclass=\"patientResources\">\n<sectiondiv>\n<p>Patient information leaflet to be provided.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP4787-medicinalForms\" outputclass=\"medicinalForms\" parent=\"/drugs/mifepristone\">\n<title>Medicinal forms</title>\n<body>\n<section outputclass=\"licensingVariationStatement\">\n<p>There can be variation in the licensing of different medicines containing the same drug.</p>\n</section>\n</body>\n</topic>\n<parents>\n<xref format=\"dita\" scope=\"local\" type=\"drugs\" href=\"#drugs\" title=\"Drugs\" namespace=\"/drugs\">Drugs</xref>\n</parents>\n<children>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP74671\" title=\"Tablet\" namespace=\"/drugs/mifepristone/tablet\">Tablet</xref>\n</children>\n<backlinks>\n<xref format=\"dita\" scope=\"local\" type=\"drugClassifications\" href=\"#PHP106980\" namespace=\"/drug-classifications\" title=\"Drug classifications\" count=\"1\" rel=\"backlink\">Drug classifications</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78629\" namespace=\"/treatment-summaries/obstetrics\" title=\"Obstetrics\" count=\"2\" rel=\"backlink\">Obstetrics</xref>\n</backlinks>\n<links>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_614\" namespace=\"/interactions/list-of-drug-interactions/mifepristone\" title=\"Mifepristone\" count=\"1\" rel=\"link\">Mifepristone</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78608\" namespace=\"/treatment-summaries/acute-porphyrias\" title=\"Acute porphyrias\" count=\"1\" rel=\"link\">Acute porphyrias</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#drugs\" href=\"#drugs\" namespace=\"/drugs\" title=\"Drugs\" count=\"1\" rel=\"link\">Drugs</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP74671\" namespace=\"/drugs/mifepristone/tablet\" title=\"Tablet\" count=\"1\" rel=\"link\">Tablet</xref>\n</links>\n</topic>",
    "id": "PHP4787",
    "outputclass": "drug",
    "rev": "1.11",
    "type": "drug",
    "namespace": "/drugs/mifepristone",
    "basename": "mifepristone",
    "title": "MIFEPRISTONE",
    "interactants": [
        {
            "id": "bnf_int_614",
            "label": "Mifepristone"
        }
    ],
    "vtmid": "129483007",
    "drugClassification": [
        "Progesterone receptor modulators"
    ],
    "primaryDomainOfEffect": {
        "": {
            "domain": "",
            "therapeuticUses": {}
        }
    },
    "drugAction": {
        "drugAction": [
            {
                "type": "drugAction",
                "textContent": "Mifepristone, an antiprogestogenic steroid, sensitises the myometrium to prostaglandin-induced contractions and ripens the cervix.",
                "html": "<p>Mifepristone, an antiprogestogenic steroid, sensitises the myometrium to prostaglandin-induced contractions and ripens the cervix.</p>"
            }
        ]
    },
    "indicationsAndDoses": {
        "indicationAndDoseGroups": [
            {
                "indications": [
                    {
                        "textContent": "Cervical ripening before mechanical cervical dilatation for termination of pregnancy of up to 84 days gestation (under close medical supervision)",
                        "html": "Cervical ripening before mechanical cervical dilatation for termination of pregnancy of up to 84 days gestation (under close medical supervision)"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "200 mg for 1 dose, to be taken 36-48 hours before procedure.",
                        "html": "<p>200&#8239;mg for 1 dose, to be taken 36-48 hours before procedure.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Labour induction in fetal death in utero where prostaglandin or oxytocin inappropriate (under close medical supervision)",
                        "html": "Labour induction in fetal death in utero where prostaglandin or oxytocin inappropriate (under close medical supervision)"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "600 mg once daily for 2 days, if labour not started within 72 hours of first dose, another method should be used.",
                        "html": "<p>600&#8239;mg once daily for 2 days, if labour not started within 72 hours of first dose, another method should be used.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Medical termination of intra-uterine pregnancy of up to 49 days gestation (under close medical supervision)",
                        "html": "Medical termination of intra-uterine pregnancy of up to 49 days gestation (under close medical supervision)"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "600 mg for 1 dose, dose followed 36&#8211;48 hours later (unless abortion already complete) by gemeprost 1 mg by vagina or misoprostol 400 micrograms by mouth, alternatively 200 mg for 1 dose, dose followed 36&#8211;48 hours later (unless abortion already complete) by gemeprost 1 mg by vagina; observe for at least 3 hours (or until bleeding or pain at acceptable level); follow-up visit within 2 weeks to verify complete expulsion and to assess vaginal bleeding.",
                        "html": "<p>600&#8239;mg for 1 dose, dose followed 36&#8211;48 hours later (unless abortion already complete) by gemeprost 1&#8239;mg by vagina <i>or</i> misoprostol 400&#8239;micrograms by mouth, alternatively 200&#8239;mg for 1 dose, dose followed 36&#8211;48 hours later (unless abortion already complete) by gemeprost 1&#8239;mg by vagina; observe for at least 3 hours (or until bleeding or pain at acceptable level); follow-up visit within 2 weeks to verify complete expulsion and to assess vaginal bleeding.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Medical termination of intra-uterine pregnancy of 50&#8211;63 days gestation (under close medical supervision)",
                        "html": "Medical termination of intra-uterine pregnancy of 50&#8211;63 days gestation (under close medical supervision)"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "600 mg for 1 dose, alternatively 200 mg for 1 dose, dose followed 36&#8211;48 hours later (unless abortion already complete) by gemeprost 1 mg by vagina; observe for at least 3 hours (or until bleeding or pain at acceptable level); follow-up visit within 2 weeks to verify complete expulsion and to assess vaginal bleeding.",
                        "html": "<p>600&#8239;mg for 1 dose, alternatively 200&#8239;mg for 1 dose, dose followed 36&#8211;48 hours later (unless abortion already complete) by gemeprost 1&#8239;mg by vagina; observe for at least 3 hours (or until bleeding or pain at acceptable level); follow-up visit within 2 weeks to verify complete expulsion and to assess vaginal bleeding.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Termination of pregnancy of 13&#8211;24 weeks gestation (in combination with a prostaglandin) (under close medical supervision)",
                        "html": "Termination of pregnancy of 13&#8211;24 weeks gestation (in combination with a prostaglandin) (under close medical supervision)"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "600 mg for 1 dose, alternatively 200 mg for 1 dose, dose followed 36&#8211;48 hours later by gemeprost 1 mg by vagina every 3 hours up to max. 5 mg or misoprostol; if abortion does not occur, 24 hours after start of treatment repeat course of gemeprost 1 mg by vagina up to max. 5 mg; follow-up visit after appropriate interval to assess vaginal bleeding recommended.",
                        "html": "<p>600&#8239;mg for 1 dose, alternatively 200&#8239;mg for 1 dose, dose followed 36&#8211;48 hours later by gemeprost 1&#8239;mg by vagina every 3 hours up to max. 5 mg <i>or</i> misoprostol; if abortion does not occur, 24 hours after start of treatment repeat course of gemeprost 1&#8239;mg by vagina up to max. 5&#8239;mg; follow-up visit after appropriate interval to assess vaginal bleeding recommended.</p>"
                    }
                ]
            }
        ]
    },
    "contraindications": {
        "contraindications": [
            {
                "type": "contraindications",
                "textContent": "Acute porphyrias",
                "html": "<xref format=\"dita\" href=\"#PHP78608\" type=\"bookmark\" namespace=\"/treatment-summaries/acute-porphyrias\">Acute porphyrias</xref>",
                "references": [
                    {
                        "id": "PHP78608",
                        "label": "Acute porphyrias"
                    }
                ]
            },
            {
                "type": "contraindications",
                "textContent": "chronic adrenal failure",
                "html": "chronic adrenal failure"
            },
            {
                "type": "contraindications",
                "textContent": "suspected ectopic pregnancy (use other specific means of termination)",
                "html": "suspected ectopic pregnancy (use other specific means of termination)"
            },
            {
                "type": "contraindications",
                "textContent": "uncontrolled severe asthma",
                "html": "uncontrolled severe asthma"
            }
        ]
    },
    "cautions": {
        "cautions": [
            {
                "type": "cautions",
                "textContent": "Adrenal suppression (may require corticosteroid)",
                "html": "Adrenal suppression (may require corticosteroid)"
            },
            {
                "type": "cautions",
                "textContent": "anticoagulant therapy",
                "html": "anticoagulant therapy"
            },
            {
                "type": "cautions",
                "textContent": "asthma (avoid if severe and uncontrolled)",
                "html": "asthma (avoid if severe and uncontrolled)"
            },
            {
                "type": "cautions",
                "textContent": "existing cardiovascular disease",
                "html": "existing cardiovascular disease"
            },
            {
                "type": "cautions",
                "textContent": "haemorrhagic disorders",
                "html": "haemorrhagic disorders"
            },
            {
                "type": "cautions",
                "textContent": "history of endocarditis",
                "html": "history of endocarditis"
            },
            {
                "type": "cautions",
                "textContent": "prosthetic heart valve",
                "html": "prosthetic heart valve"
            },
            {
                "type": "cautions",
                "textContent": "risk factors for cardiovascular disease",
                "html": "risk factors for cardiovascular disease"
            }
        ]
    },
    "interactions": {
        "general": [
            {
                "type": "general",
                "textContent": "Appendix 1 (mifepristone).",
                "html": "<p>Appendix 1 (mifepristone).</p>"
            }
        ]
    },
    "sideEffects": {
        "general": {
            "frequencies": {
                "commonOrVeryCommon": [
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "Gastro-intestinal cramps",
                        "html": "Gastro-intestinal cramps",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "uterine contractions",
                        "html": "uterine contractions",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "vaginal bleeding (sometimes severe) may occur between administration of mifepristone and surgery (and rarely abortion may occur before surgery)",
                        "html": "vaginal bleeding (sometimes severe) may occur between administration of mifepristone and surgery (and rarely abortion may occur before surgery)",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    }
                ],
                "uncommon": [
                    {
                        "type": "uncommon",
                        "textContent": "Hypersensitivity reactions",
                        "html": "Hypersensitivity reactions",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "rash",
                        "html": "rash",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "urticaria",
                        "html": "urticaria",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    }
                ],
                "rare": [
                    {
                        "type": "rare",
                        "textContent": "Chills",
                        "html": "Chills",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    },
                    {
                        "type": "rare",
                        "textContent": "dizziness",
                        "html": "dizziness",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    },
                    {
                        "type": "rare",
                        "textContent": "fever",
                        "html": "fever",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    },
                    {
                        "type": "rare",
                        "textContent": "headache",
                        "html": "headache",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    },
                    {
                        "type": "rare",
                        "textContent": "hot flushes",
                        "html": "hot flushes",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    },
                    {
                        "type": "rare",
                        "textContent": "hypotension",
                        "html": "hypotension",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    },
                    {
                        "type": "rare",
                        "textContent": "malaise",
                        "html": "malaise",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    }
                ],
                "notKnown": [
                    {
                        "type": "notKnown",
                        "textContent": "Infections",
                        "html": "Infections",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "toxic shock syndrome",
                        "html": "toxic shock syndrome",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    }
                ]
            }
        }
    },
    "hepaticImpairment": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Manufacturer advises avoid.",
                "html": "<p>Manufacturer advises avoid.</p>"
            }
        ]
    },
    "renalImpairment": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Manufacturer advises avoid.",
                "html": "<p>Manufacturer advises avoid.</p>"
            }
        ]
    },
    "monitoringRequirements": {
        "patientParameters": [
            {
                "type": "patientParameters",
                "textContent": "Careful monitoring of blood pressure and pulse essential for 3 hours after administration of gemeprost pessary (risk of profound hypotension).",
                "html": "<p>Careful monitoring of blood pressure and pulse essential for 3 hours after administration of gemeprost pessary (risk of profound hypotension).</p>"
            }
        ]
    },
    "prescribingAndDispensingInformation": {
        "prescribingAndDispensingInformation": [
            {
                "type": "prescribingAndDispensingInformation",
                "textContent": "Supplied to NHS hospitals and premises approved under Abortion Act 1967.",
                "html": "<p>Supplied to NHS hospitals and premises approved under Abortion Act 1967.</p>"
            }
        ]
    },
    "patientAndCarerAdvice": {
        "patientResources": [
            {
                "type": "patientResources",
                "textContent": "Patient information leaflet to be provided.",
                "html": "<p>Patient information leaflet to be provided.</p>"
            }
        ]
    },
    "medicinalForms": {
        "licensingVariationStatement": [
            {
                "type": "licensingVariationStatement",
                "textContent": "There can be variation in the licensing of different medicines containing the same drug.",
                "html": "<p>There can be variation in the licensing of different medicines containing the same drug.</p>"
            }
        ]
    },
    "children": {
        "medicinalForm": [
            {
                "id": "PHP74671",
                "label": "Tablet",
                "type": "medicinalForm"
            }
        ]
    },
    "backlinks": {
        "drugClassifications": [
            {
                "id": "PHP106980",
                "label": "Drug classifications",
                "type": "drugClassifications"
            }
        ],
        "treatmentSummary": [
            {
                "id": "PHP78629",
                "label": "Obstetrics",
                "type": "treatmentSummary"
            }
        ]
    },
    "links": {
        "interaction": [
            {
                "id": "bnf_int_614",
                "label": "Mifepristone",
                "type": "interaction"
            }
        ],
        "treatmentSummary": [
            {
                "id": "PHP78608",
                "label": "Acute porphyrias",
                "type": "treatmentSummary"
            }
        ],
        "#drugs": [
            {
                "id": "drugs",
                "label": "Drugs",
                "type": "#drugs"
            }
        ],
        "medicinalForm": [
            {
                "id": "PHP74671",
                "label": "Tablet",
                "type": "medicinalForm"
            }
        ]
    }
}